Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SI-6603 in patients with lumbar disc herniation
NCT01282606Phase 2Completed
- Sponsor
- Seikagaku Corporation
- Start
- Dec 2007
- Primary completion
- Aug 2012
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of condoliase in lumbar disc herniation (LDH), sponsored by Seikagaku Corporation. Started Dec 2007; status: completed.
02
Drugs
condoliase
03
Conditions
lumbar disc herniation (LDH)
Beyond the preview
Go deeper on NCT01282606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01282606.